Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Stochastic extinction of epidemics: how long would it take for SARS-Cov-2 to die out without herd immunity?

View ORCID ProfileBhavin S. Khatri
doi: https://doi.org/10.1101/2020.08.10.20171454
Bhavin S. Khatri
1Department of Life Sciences, Imperial College London, Silwood Park, Ascot, SL5 7PY
2The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bhavin S. Khatri
  • For correspondence: bhavin.khatri@physics.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Worldwide, we are currently in an unprecedented situation with regard to the SARS-Cov-2 epidemic, where countries are using isolation and lock-down measures to control the spread of infection. This is a scenario generally not much anticipated by previous theory, and in particular, there has been little attention paid to the question of extinction as a means to eradicate the virus; the prevailing view appears to be that this is unfeasible without a vaccine. We use a simple well-mixed stochastic SIR model as a basis for our considerations, and calculate a new result, using branching process theory, for the distribution of times to extinction. Surprisingly, the distribution is an extreme value distribution of the Gumbel type, and we show that the key parameter determining its mean and standard deviation is the expected rate of decline ρe = γ(1 − Re) of infections, where γ is the rate of recovery from infection and Re is the usual effective reproductive number. The result also reveals a critical threshold number of infected I† = 1/(1 − Re), below which stochastic forces dominate and need be considered for accurate predictions. As this theory ignores migration between populations, we compare against a realistic spatial epidemic simulator and simple stochastic simulations of sub-divided populations with global migration, to find very comparable results to our simple predictions; in particular, we find global migration has the effect of a simple upwards rescaling of Re with the same Gumbel extinction time distribution we derive from our non-spatial model. Within the UK, assuming no migration, using recent estimates of ≈ 37, 000 infected and Re ≈ 0.9, this model predicts a mean extinction time of 616 ± 90 days or approximately 2 years, but could be as short as 123 ± 15 days, or roughly 4 months for Re = 0.4 — in practice, while there is prevalence of infections globally, it is likely that nations can only at best achieve quasi-extinction, a state of temporary extinction, when immigration of cases is rare. This highlights the importance of a global decline in infections, and here the theory predicts extinction in less than 200 days, if the reproductive number is restricted to Re < 0.5. Overall, these results highlight the extreme sensitivity of extinction times when Re approaches 1 and the necessity of reducing the effective reproductive number significantly (Re ≲ 0.5) for relatively rapid extinction of an epidemic or pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Correction of typo in title General clarification and extra discussion of practically what extinction means for a country when there are still infections globally. Other small changes/corrections.

Data Availability

Code to plot extinction time predictions and distributions, as well as for performing the Gillespie simulations can be found at https://github.com/BhavKhatri/Stochastic-Extinction-Epidemic.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Stochastic extinction of epidemics: how long would it take for SARS-Cov-2 to die out without herd immunity?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Stochastic extinction of epidemics: how long would it take for SARS-Cov-2 to die out without herd immunity?
Bhavin S. Khatri
medRxiv 2020.08.10.20171454; doi: https://doi.org/10.1101/2020.08.10.20171454
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Stochastic extinction of epidemics: how long would it take for SARS-Cov-2 to die out without herd immunity?
Bhavin S. Khatri
medRxiv 2020.08.10.20171454; doi: https://doi.org/10.1101/2020.08.10.20171454

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1425)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (585)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5018)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)